Search research articles
Contact Us
Filters
Showing results (71-80 of 265) with videos related to
Page
of 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2006
Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial
Bernardo Bonanni, Debora Macis, Patrick Maisonneuve, et al.
Cancers
|
October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
Caterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
Oncology Letters
|
August 10, 2017
Hereditary diffuse gastric cancer in two families: A case report
Irene Feroce, Davide Serrano, Roberto Biffi, et al.
Cancers
|
April 3, 2021
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review
Giovanni Corso, Federica Corso, Federica Bellerba, et al.
Breast Cancer Research and Treatment
|
August 4, 2016
A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen
Harriet Johansson, Sara Gandini, Davide Serrano, et al.
Annals of Surgical Oncology
|
August 4, 2009
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Carlos A Garcia-Etienne, Monica Barile, Oreste D Gentilini, et al.
The Lancet. Oncology
|
December 9, 2023
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial
Jack Cuzick, Kim Chu, Brian Keevil, et al.
Breast Cancer Research and Treatment
|
November 19, 2013
Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide
Harriet Johansson, Bernardo Bonanni, Sara Gandini, et al.
Circulation
|
September 5, 2002
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women
Andrea Decensi, Umberto Omodei, Chris Robertson, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
March 10, 2017
BRCA1/2 germline missense mutations: a systematic review
Giovanni Corso, Irene Feroce, Mattia Intra, et al.
Page
of 27
Search research articles
Search
Showing results (71-80 of 265) with videos related to
Sort By:
Page
of 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2006
Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial
Bernardo Bonanni, Debora Macis, Patrick Maisonneuve, et al.
Cancers
|
October 27, 2019
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy
Caterina Fumagalli, Federica Tomao, Ilaria Betella, et al.
Oncology Letters
|
August 10, 2017
Hereditary diffuse gastric cancer in two families: A case report
Irene Feroce, Davide Serrano, Roberto Biffi, et al.
Cancers
|
April 3, 2021
Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review
Giovanni Corso, Federica Corso, Federica Bellerba, et al.
Breast Cancer Research and Treatment
|
August 4, 2016
A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen
Harriet Johansson, Sara Gandini, Davide Serrano, et al.
Annals of Surgical Oncology
|
August 4, 2009
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Carlos A Garcia-Etienne, Monica Barile, Oreste D Gentilini, et al.
The Lancet. Oncology
|
December 9, 2023
Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial
Jack Cuzick, Kim Chu, Brian Keevil, et al.
Breast Cancer Research and Treatment
|
November 19, 2013
Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide
Harriet Johansson, Bernardo Bonanni, Sara Gandini, et al.
Circulation
|
September 5, 2002
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women
Andrea Decensi, Umberto Omodei, Chris Robertson, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
March 10, 2017
BRCA1/2 germline missense mutations: a systematic review
Giovanni Corso, Irene Feroce, Mattia Intra, et al.
Page
of 27